1. Home
  2. JAGX vs ATPC Comparison

JAGX vs ATPC Comparison

Compare JAGX & ATPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jaguar Health Inc.

JAGX

Jaguar Health Inc.

HOLD

Current Price

$2.81

Market Cap

2.2M

Sector

Health Care

ML Signal

HOLD

Logo Agape ATP Corporation

ATPC

Agape ATP Corporation

HOLD

Current Price

$2.83

Market Cap

2.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JAGX
ATPC
Founded
2013
2016
Country
United States
Malaysia
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Nursing Services
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2M
2.2M
IPO Year
2014
2017

Fundamental Metrics

Financial Performance
Metric
JAGX
ATPC
Price
$2.81
$2.83
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$60.00
N/A
AVG Volume (30 Days)
62.4K
3.4M
Earning Date
04-07-2026
04-13-2026
Dividend Yield
N/A
N/A
EPS Growth
82.42
N/A
EPS
N/A
N/A
Revenue
$11,511,000.00
$1,524,262.00
Revenue This Year
$61.58
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
15.23
52 Week Low
$0.22
$0.05
52 Week High
$8.00
$8.50

Technical Indicators

Market Signals
Indicator
JAGX
ATPC
Relative Strength Index (RSI) 50.55 46.60
Support Level $1.76 $1.93
Resistance Level $4.13 $3.50
Average True Range (ATR) 0.27 0.45
MACD 0.03 -0.06
Stochastic Oscillator 72.63 6.80

Price Performance

Historical Comparison
JAGX
ATPC

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceutical company developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for gastrointestinal disease states in humans and animals. The Company focuses on conditions associated with overactive bowel, including chronic debilitating diarrhea, urgency, and bowel incontinence. It operates through two segments: animal health, which develops and commercializes products for animals, and human health, with the human health segment generating the maximum revenue and focusing on products such as Mytesi, focusing on human products, specifically Mytesi, approved for symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.

About ATPC Agape ATP Corporation

Agape ATP Corp through its subsidiaries is engaged in providing health and wellness products and health solution advisory services. The principal activities of the company is to supply high-quality health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system of the human body and various wellness programs. Its segments include: Skin care, health and wellness segment includes the provision of health and wellness products and health solution advisory services; and Green energy segment includes providing renewable energy products, technical solutions, installations and maintenance services. It derives maximum revenue from Skin care, health and wellness segment.

Share on Social Networks: